Company: PGEN
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001356090-25-000034
Chunk: 24

Company: PRECIGEN, INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 24
---
,513)Other Income (Expense), NetChange in fair value of warrant liabilities(111,502)— (139,523)— Interest expense(902)(2)(903)(6)Interest income534 283 2,148 1,210 Other (expense) income, net7 (2,985)(17)(2,905)Total other expense, net(111,863)(2,704)(138,295)(1,701)Loss before income taxes(146,344)(23,966)(227,136)(108,214)Income tax (expense) benefit— (12)(3)1,706 Net loss$(146,344)$(23,978)$(227,139)$(106,508)Deemed dividend on preferred stock(179,000)— (179,000)— Net loss attributable to common shareholders$(325,344)$(23,978)$(406,139)$(106,508)Net loss per share attributable to common shareholders Net loss per share attributable to common shareholders, basic and diluted$(1.06)$(0.09)$(1.36)$(0.41)Weighted average shares outstanding, basic and diluted307,170,490 275,881,170 299,210,344 259,254,775 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Precigen, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Loss

(Unaudited) 

 Three Months Ended  September 30,Nine Months Ended  September 30,(Amounts in thousands)2025202420252024Net loss$(146,344)$(23,978)$(227,139)$(106,508)Other comprehensive loss:Unrealized gain on investments13 29 12 44 Loss on foreign currency translation adjustments— (22)— (999)Reclassification of cumulative foreign currency translation adjustments to other income, net— 2,915 — 2,915 Comprehensive loss$(146,331)$(21,056)$(227,127)$(104,548)Deemed dividend on preferred stock(179,000)— (179,000)— Comprehensive loss attributable to common shareholders $(325,331)$(21,056)$(406,127)$(104,548)

The accompanying notes are an integral part of these condensed consolidated financial statements.

7

Precigen,